| Patient | Zora Neale Hurston |
|---|---|
| Date of birth | 1959-01-07 |
| Identifiers | MRN HR-ML040-SYN; SSN (made up) 000-40-6213 |
| Document date | 2026-03-09 |
| Author | Lorraine Abernathy-Osei, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
The patient attends this visit for establishing care for morning headaches, breathlessness on exertion and ankle swelling, with very high blood pressure: examination, ECG, laboratory tests, 24-hour ambulatory blood pressure monitoring, a two-drug combination, food and medicine-cost screening, and stroke warning signs. [S]
NT-proBNP: 480 pg/mL (high); Sodium: 140 mmol/L; Potassium: 3.9 mmol/L; Creatinine: 0.88 mg/dL; eGFR (CKD-EPI 2021): 72 mL/min/1.73 m²; Glucose: 96 mg/dL; Magnesium: 2 mg/dL; Hemoglobin: 12.4 g/dL; TSH: 1.9 mIU/L; Hemoglobin A1c: 5.6%; Total cholesterol: 212 mg/dL (high); LDL cholesterol: 132 mg/dL (high); HDL cholesterol: 54 mg/dL; Triglycerides: 130 mg/dL; ALT: 18 U/L; Urine albumin-to-creatinine ratio: 22 mg/g; PHQ-2: 1. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-09 | Body height | 165 | cm | S |
| 2026-03-09 | Body weight | 84.2 | kg | S |
| 2026-03-09 | Body mass index (BMI) [Ratio] | 30.9 | kg/m2 | S |
| 2026-03-09 | Systolic blood pressure | 176 | mm[Hg] | S |
| 2026-03-09 | Diastolic blood pressure | 103 | mm[Hg] | S |
| 2026-03-09 | Heart rate | 82 | /min | S |
| 2026-03-09 | Respiratory rate | 18 | /min | S |
| 2026-03-09 | Body temperature | 36.7 | Cel | S |
| 2026-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-09 | Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma | 480 | pg/mL | Below 125 pg/mL makes heart failure unlikely outside the hospital | High | S |
| 2026-03-09 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-03-09 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-03-09 | Creatinine [Mass/volume] in Serum or Plasma | 0.88 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 2026-03-09 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 72 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-03-09 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-03-09 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.6-2.6 mg/dL | Normal | S |
| 2026-03-09 | Hemoglobin [Mass/volume] in Blood | 12.4 | g/dL | 11.6-15 g/dL | Normal | S |
| 2026-03-09 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-03-09 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | <=5.6% | Normal | S |
| 2026-03-09 | Cholesterol [Mass/volume] in Serum or Plasma | 212 | mg/dL | <=199 mg/dL | High | S |
| 2026-03-09 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 132 | mg/dL | <=99 mg/dL | High | S |
| 2026-03-09 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 54 | mg/dL | >=50 mg/dL | Normal | S |
| 2026-03-09 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-03-09 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 18 | U/L | 7-35 U/L | Normal | S |
| 2026-03-09 | Albumin/Creatinine [Mass Ratio] in Urine | 22 | mg/g | Below 30 mg/g is normal | Normal | S |
| 2026-03-09 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 1 | {score} | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet, one tablet every morning | One tablet every morning | Oral route | 2026-03-09 | active | S |
| Chlorthalidone 25 mg oral tablet, one-half tablet (12.5 mg) every morning | One-half tablet every morning | Oral route | 2026-03-09 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Very high blood pressure at intake (178/104 and 174/102 mmHg) with morning headaches for two months, without signs of a hypertensive emergency; not previously diagnosed; ambulatory monitoring to confirm | active | confirmed | R03.0 | S — Synthetic presenting problem, resolved when ambulatory monitoring and the echocardiogram established the diagnosis at the second visit. Not a claim about her real blood pressure. |
| Breathlessness on exertion for three months (walking to the school, carrying groceries) with mild ankle swelling by evening; cause to be determined | active | confirmed | R06.09 | S — Synthetic presenting problem, resolved into the heart failure diagnosis at the second visit. |
| Food insecurity: food runs short at the end of most months (Hunger Vital Sign positive) | active | confirmed | Z59.41 | S — Synthetic social need anchored to her documented poverty. |
| Low and irregular income from substitute teaching and newspaper writing, with Original Medicare but no drug coverage; medicine costs a barrier | active | confirmed | Z59.6 | S — Synthetic social need anchored to her documented low income in the 1950s. |